Impact of daily administration of teriparatide on the histological pattern of testicular structure in adult male rats

<p><strong>Aim </strong>Teriparatide, a synthetic analog of the active fragment of human parathyroid hormone (PTH 1–34), is a clinically approved anabolic treatment for osteoporosis. While its bone-forming capacity is well-documented, evidence regarding its systemic safety, particularly in relation to male reproductive health, remains limited.</p> <p><strong>Aim:</strong> This study was designed to investigate the histological consequences of prolonged teriparatide exposure on testicular architecture in adult male rats, addressing a critical gap in its toxicological profile.</p> <p><strong>Methods</strong> Twenty adult male albino rats were randomly allocated into two groups. The control group received subcutaneous saline (1 mL/kg/day), while and the treated group was administered teriparatide (10 µg/kg/day) daily for 60 days. Testes were collected post-euthanasia, fixed in formalin, and processed for histological examination. Spermatogenic activity was assessed using Johnsen’s scoring system, and morphometric parameters, including seminiferous tubule diameter and epithelial height, were quantified. Statistical significance was determined using the Mann–Whitney U test (p≤0.05).</p> <p><strong>Results </strong>Histological findings revealed preserved cytoarchitecture with active spermatogenesis in control testes. The teriparatide-treated group exhibited significant degenerative changes, including epithelial detachment, interstitial edema, vascular congestion, and Leydig cell necrosis. Johnsen’s scores were significantly reduced in the treated group (median = 4.5; IQR=1.5) compared to controls (median = 8.0; IQR=2.0; p<0.001). Furthermore, Seminiferous tubule diameter and epithelial height were markedly decreased in the treated animals.</p> <p><strong>Conclusion </strong>The findings suggest that prolonged teriparatide exposure may impair permatogenesis and alter testicular structure. Re-evaluation of its reproductive safety is warranted, particularly for males of reproductive age.</p>

Authors

Institutions

Publication Details

Journal
Medicinski Glasnik
Published
2026-02-27
DOI
https://doi.org/10.17392/2033-23-01
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of daily administration of teriparatide on the histological pattern of testicular structure in adult male rats

Omar M. Ameen, Ghada Taqa
Medicinski Glasnik
Bone health and osteoporosis research
article

Impact of daily administration of teriparatide on the histological pattern of testicular structure in adult male rats

Omar M. Ameen, Ghada Taqa
article en

Abstract

<p><strong>Aim </strong>Teriparatide, a synthetic analog of the active fragment of human parathyroid hormone (PTH 1–34), is a clinically approved anabolic treatment for osteoporosis. While its bone-forming capacity is well-documented, evidence regarding its systemic safety, particularly in relation to male reproductive health, remains limited.</p> <p><strong>Aim:</strong> This study was designed to investigate the histological consequences of prolonged teriparatide exposure on testicular architecture in adult male rats, addressing a critical gap in its toxicological profile.</p> <p><strong>Methods</strong> Twenty adult male albino rats were randomly allocated into two groups. The control group received subcutaneous saline (1 mL/kg/day), while and the treated group was administered teriparatide (10 µg/kg/day) daily for 60 days. Testes were collected post-euthanasia, fixed in formalin, and processed for histological examination. Spermatogenic activity was assessed using Johnsen’s scoring system, and morphometric parameters, including seminiferous tubule diameter and epithelial height, were quantified. Statistical significance was determined using the Mann–Whitney U test (p≤0.05).</p> <p><strong>Results </strong>Histological findings revealed preserved cytoarchitecture with active spermatogenesis in control testes. The teriparatide-treated group exhibited significant degenerative changes, including epithelial detachment, interstitial edema, vascular congestion, and Leydig cell necrosis. Johnsen’s scores were significantly reduced in the treated group (median = 4.5; IQR=1.5) compared to controls (median = 8.0; IQR=2.0; p<0.001). Furthermore, Seminiferous tubule diameter and epithelial height were markedly decreased in the treated animals.</p> <p><strong>Conclusion </strong>The findings suggest that prolonged teriparatide exposure may impair permatogenesis and alter testicular structure. Re-evaluation of its reproductive safety is warranted, particularly for males of reproductive age.</p>

Medicinski GlasnikVol. 23(1)
University of Mosul (IQ)
Good health and well-being
Openalex Percentile: Top 42%
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.